Myomo (MYO) FCF Margin Growth (3y) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 38.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 30.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 943.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 96.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -2,196.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -20.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2,679.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -461.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 417.00 |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 4,212.00 |
| Jun 30, 2025 | -3,838.00 |
| Mar 31, 2025 | 3,411.00 |
| Dec 31, 2024 | 6,671.00 |
| Sep 30, 2024 | 3,216.00 |
| Jun 30, 2024 | 8,860.00 |
| Mar 31, 2024 | 429.00 |
| Dec 31, 2023 | -1,989.00 |
| Sep 30, 2023 | 5,977.00 |
| Jun 30, 2023 | 42,065.00 |
| Mar 31, 2023 | 18,929.00 |
| Dec 31, 2022 | 11,372.00 |
| Sep 30, 2022 | 30,743.00 |
| Jun 30, 2022 | 18,976.00 |
| Mar 31, 2022 | 31,517.00 |
| Dec 31, 2021 | 23,761.00 |
| Sep 30, 2021 | 36,175.00 |
| Jun 30, 2021 | 25,778.00 |
| Mar 31, 2021 | 65,175.00 |
| Dec 31, 2020 | 203,293.00 |
| Sep 30, 2020 | 28,747.00 |
| Jun 30, 2020 | 9,145.00 |
| Mar 31, 2020 | 605,945.00 |
| Dec 31, 2019 | 2,693.00 |
| Sep 30, 2019 | 33,545.00 |